Sycomore Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.5M Hold
20,238
2.31% 9
2026
Q1
$18.4M Hold
20,238
2.56% 10
2025
Q4
$18.4M Hold
20,238
3.04% 8
2025
Q3
$18.4M Hold
20,238
3.06% 8
2025
Q2
$18.4M Hold
20,238
2.86% 8
2025
Q1
$18.4M Hold
20,238
2.61% 9
2024
Q4
$18.4M Sell
20,238
-813
-4% -$673K 2.62% 9
2024
Q3
$19.1M Sell
21,051
-17,962
-46% -$16.1M 3.18% 6
2024
Q2
$35.2M Buy
39,013
+26,282
+206% +$21M 6.18% 3
2024
Q1
$9.7M Buy
12,731
+8,494
+200% +$6.04M 2.12% 16
2023
Q4
$2.46M Buy
4,237
+3,462
+447% +$2.02M 0.53% 49
2023
Q3
$427K Buy
775
+19
+3% +$9.79K 0.11% 64
2023
Q2
$347K Buy
756
+524
+226% +$220K 0.08% 63
2023
Q1
$78K Buy
232
+33
+17% +$11.1K 0.02% 77
2022
Q4
$73K Hold
199
0.02% 89
2022
Q3
$61K Hold
199
0.02% 103
2022
Q2
$63K Buy
+199
New +$59.7K 0.01% 102

Other funds holding LLY

Sycomore Asset Management's LLY Position: Q2 2026 in Review

Sycomore Asset Management held its Eli Lilly (LLY) position steady in Q2 2026 at 20,238 shares worth $21.5M. The position accounts for 2.31% of the portfolio, ranked #9.

Sycomore Asset Management first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. The position peaked at $35.2M in Q2 2024. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sycomore Asset Management held 20,238 shares of Eli Lilly worth $21.5M as of Q2 2026.
  • Sycomore Asset Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 2.31% of Sycomore Asset Management's portfolio in Q2 2026, its #9 holding.
  • Sycomore Asset Management first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • Sycomore Asset Management's Eli Lilly position peaked at $35.2M in Q2 2024.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sycomore Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.